Article ID Journal Published Year Pages File Type
5665779 Diagnostic Microbiology and Infectious Disease 2017 4 Pages PDF
Abstract

•Agreement with the manufacturer's methodology was >90% for TB first line drugs.•Subculturing of M. tuberculosis isolates in MGIT as recommended can be excluded.•Modified protocol is more rapid and has lower cost than manufacturer's methodology.

A rapid detection of resistance in Mycobacterium tuberculosis is crucial for management and control of tuberculosis. This study evaluated a more rapid and cost-effective drug susceptibility testing (DST) protocol using primary isolates of M. tuberculosis in mycobacteria growth indicator tube (MGIT). Ninety-four M. tuberculosis isolates in MGIT were subjected to DST by the manufacturer's method, i.e., primary isolates were subcultured and DST was performed from positive cultures for a maximum of 5 days; and by our modified method, i.e., DST was performed directly from primary MGIT cultures positive for more than 5 days. Results were concordant for 76 (81%) isolates. Agreement between both methods was 92.0%, 98.9%, 97.7%, and 95.5% for streptomycin, isoniazid, rifampicin, and ethambutol, respectively. Six isolates failed to grow on the recommended method, including 3 resistant isolates. Not performing subculture of primary M. tuberculosis isolates yields reliable results, decreasing the turnaround time and the cost of the test.

Related Topics
Life Sciences Immunology and Microbiology Applied Microbiology and Biotechnology
Authors
, , , , , ,